{"id":561,"date":"2022-05-19T15:00:21","date_gmt":"2022-05-19T15:00:21","guid":{"rendered":"https:\/\/medicalmarijuanainc.com\/?p=1013653"},"modified":"2022-05-19T15:00:21","modified_gmt":"2022-05-19T15:00:21","slug":"medical-marijuana-inc-reports-7-8-million-in-net-revenue-in-2022-first-quarter-financial-and-operational-results","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2022\/05\/19\/medical-marijuana-inc-reports-7-8-million-in-net-revenue-in-2022-first-quarter-financial-and-operational-results\/","title":{"rendered":"Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results"},"content":{"rendered":"

SAN DIEGO, CA, May 19, 2022 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire\u00a0<\/a>\u00a0\u2013\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending March 31, 2022, and provided an overview of recent operational highlights.<\/p>\n

First Quarter 2022 Financial and Operational Highlights<\/b><\/p>\n